← All trials
NCT07290088
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 9, 2023
- Primary completion
- Feb 28, 2026
- Completion date
- Feb 28, 2026
- First posted
- Dec 17, 2025
- Last posted
- Dec 17, 2025
- Enrollment
- 52
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- INTRA-IMMUSG PRIVATE LIMITEDLead sponsor
- Univerisiti Sains MalaysiaCollaborator
- INTRA-IMMUSG PRIVATE LIMITEDOfficial
- Kuala Lumpur General HospitalCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.